Exec Chat: As Reimbursement Questions Get Answers, iRhythm Looks To The Future

Medtech Insight caught up again with iRhythm CEO Quentin Blackford about his vision for the company as it plans for the next five to ten years of expansion in the remote cardiac monitoring and arrhythmia diagnostics market.

Zio XT Patch Side View
iRhythm's Zio XT long-term remote cardiac monitoring patch • Source: iRhythm

More from Patient Monitoring

More from Device Area